Zanelatto, A.d.C.O.; Lacerda, G.d.S.; Accardo, C.d.M.; Rosário, N.F.d.; Silva, A.A.d.; Motta, G.; Tersariol, I.L.d.S.; Xavier, A.R.
Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection. Microorganisms 2022, 10, 1769.
https://doi.org/10.3390/microorganisms10091769
AMA Style
Zanelatto AdCO, Lacerda GdS, Accardo CdM, Rosário NFd, Silva AAd, Motta G, Tersariol ILdS, Xavier AR.
Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection. Microorganisms. 2022; 10(9):1769.
https://doi.org/10.3390/microorganisms10091769
Chicago/Turabian Style
Zanelatto, Alexia de Cassia Oliveira, Gilmar de Souza Lacerda, Camila de Melo Accardo, Natalia Fonseca do Rosário, Andréa Alice da Silva, Guacyara Motta, Ivarne Luis dos Santos Tersariol, and Analucia Rampazzo Xavier.
2022. "Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection" Microorganisms 10, no. 9: 1769.
https://doi.org/10.3390/microorganisms10091769
APA Style
Zanelatto, A. d. C. O., Lacerda, G. d. S., Accardo, C. d. M., Rosário, N. F. d., Silva, A. A. d., Motta, G., Tersariol, I. L. d. S., & Xavier, A. R.
(2022). Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection. Microorganisms, 10(9), 1769.
https://doi.org/10.3390/microorganisms10091769
